Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.

R Brad Jones, Vivek M John, Diana V Hunter, Eric Martin, Shariq Mujib, Vesna Mihajlovic, Peter C Burgers, Theo M Luider, Gabor Gyenes, Neil C Sheppard, Devi Sengupta, Ravi Tandon, Feng-Yun Yue, Erika Benko, Colin Kovacs, Douglas F Nixon, Mario A Ostrowski
Author Information
  1. R Brad Jones: Department of Immunology, University of Toronto, Toronto, Ontario, Canada. brad.jones@utoronto.ca

Abstract

T-cell responses to human endogenous retrovirus (HERV) K(HML-2) Gag and Env were mapped in HIV-1-infected subjects using 15 mer peptides. Small peptide pools and high concentrations were used to maximize sensitivity. In the 23 subjects studied, only three bona fide HERV-K(HML-2)-specific responses were detected. At these high peptide concentrations, we detected false-positive responses, three of which were mapped to an HIV-1 Gag peptide contaminant. Thus, HERV-K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected by 15 mer peptide mapping.

References

  1. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13404-8 [PMID: 10557333]
  2. J Virol. 2011 Nov;85(21):11526-31 [PMID: 21880743]
  3. J Virol. 2001 Dec;75(24):11983-91 [PMID: 11711588]
  4. Biochem Cell Biol. 1997;75(2):143-51 [PMID: 9250362]
  5. Nat Genet. 1999 Mar;21(3):257-8 [PMID: 10080172]
  6. J Virol. 1999 Nov;73(11):9496-507 [PMID: 10516058]
  7. J Immunol Methods. 2003 Apr 1;275(1-2):19-29 [PMID: 12667667]
  8. Genomics. 2001 Mar 15;72(3):314-20 [PMID: 11401447]
  9. AIDS. 2004 Jul 23;18(11):1595-8 [PMID: 15238779]
  10. J Virol. 2005 Dec;79(24):15573-7 [PMID: 16306628]
  11. J Virol. 2011 Jul;85(14):6977-85 [PMID: 21525339]
  12. J Immunol. 1998 Jul 1;161(1):112-21 [PMID: 9647214]
  13. Curr Biol. 2001 Oct 2;11(19):1531-5 [PMID: 11591322]
  14. J Virol. 2000 Apr;74(8):3715-30 [PMID: 10729147]
  15. J Virol. 2003 Feb;77(3):2081-92 [PMID: 12525643]
  16. Clin Vaccine Immunol. 2008 Feb;15(2):267-76 [PMID: 18077621]
  17. J Clin Invest. 2008 Mar;118(3):1099-109 [PMID: 18292810]
  18. Cytometry A. 2008 Nov;73(11):1079-85 [PMID: 18727061]
  19. Rapid Commun Mass Spectrom. 2007;21(7):1282-8 [PMID: 17340558]
  20. J Immunol Methods. 2002 Sep 1;267(1):71-7 [PMID: 12135801]
  21. Retrovirology. 2005 Aug 10;2:50 [PMID: 16092962]
  22. Hum Immunol. 2004 May;65(5):523-36 [PMID: 15172453]
  23. Annu Rev Genomics Hum Genet. 2006;7:149-73 [PMID: 16722807]
  24. J Virol. 2009 Sep;83(17):8722-32 [PMID: 19553327]
  25. Curr Biol. 1999 Aug 26;9(16):861-8 [PMID: 10469592]
  26. AIDS Res Hum Retroviruses. 1993 Apr;9(4):343-50 [PMID: 8512750]
  27. Nature. 1988 Dec 1;336(6198):484-7 [PMID: 2461519]
  28. PLoS Pathog. 2007 Nov;3(11):e165 [PMID: 17997601]
  29. J Virol. 1999 Mar;73(3):2365-75 [PMID: 9971820]
  30. J Exp Med. 2008 Nov 24;205(12):2763-79 [PMID: 19001139]

Grants

  1. R56 AI084113/NIAID NIH HHS
  2. AI076059/NIAID NIH HHS
  3. AI084113/NIAID NIH HHS
  4. P30 AI027763/NIAID NIH HHS
  5. R01 AI076059/NIAID NIH HHS

MeSH Term

Endogenous Retroviruses
Gene Products, env
Gene Products, gag
HIV Infections
HIV-1
Humans
Peptide Mapping
RNA, Viral
T-Lymphocytes

Chemicals

Gene Products, env
Gene Products, gag
RNA, Viral

Word Cloud

Created with Highcharts 10.0.0responsespeptideHML-2detectedT-cellsubjectsendogenousretrovirusKGagmappedHIV-1-infectedusing15merhighconcentrationsthreeHERV-KGag-Env-specificinfrequentlyhumanHERVEnvpeptidesSmallpoolsusedmaximizesensitivity23studiedbonafide-specificfalse-positiveHIV-1contaminantThusmappingHumanstandardmatrix-basedscreening

Similar Articles

Cited By (9)